Collagen Matrix, a regenerative medicine company, completed the acquisition of Polyganics, a medical technology company. Financial terms were not disclosed. “We’re laser focused on establishing Collagen Matrix as a global leader in regenerative medicine solutions. Polyganics is our third acquisition since Linden’s investment three years ago,” Shawn McCarthy, Collagen Matrix CEO.